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Background
This work is intended to establish a relation between two
diseases, medical and psychiatric, both of them considered
public health issues – chronic hepatitis C and depression.
Interferon has been a great progress for the chronic hepa-
titis C patients’ therapy, but the treatment is encumbered
by the occurrence of depression on 3-57% of patients. The
purpose of this work is to assess the percent of the depres-
sive disorder on chronic hepatitis C patients treated with
interferon and ribavirin, as well as the monitoring of the
related risk factors, upon depression occurrence and the
evolution during anti-depressive treatment.
Methods
The retrospective study has been performed during the
period of January 2011-January 2014 on a group of 64
patients with chronic hepatitis C, receiving combined anti-
viral treatment (interferon and ribavirin), aged between
25-64 years, observing the criteria of inclusion into treat-
ment. The moment of psychiatric examination request has
been recorded, 3.1% needing psychiatric examination
before starting the therapy, 28.1% having symptoms which
occurred during treatment.
Results
The psychiatric examination has revealed as speeding
causes of the depressive disorder the loss of social support
for 39.5%, the biologic syndrome for 23%, and the loss of
family support for 15.4%, and the depressive history for
only 5.5%. The percent of the depressive patients after the
starting moment of the antiviral therapy has emphasized
the occurrence of the depressive disorder on 83% of
patients during the first 0-12 weeks. The maximum inci-
dence of cases has been recorded on patients with ages
between 20-45 years. The cases distribution has been
favorable to patients from urban area -15 cases, versus 3
cases from rural area.
Conclusion
The antiviral therapy for chronic hepatitis C has deter-
mined the occurrence of different levels of depression
for 28.1% of the patients being studied. The anti-depres-
sive treatment associated with the antiviral one has been
efficient, decreasing the abandon rate of the antiviral
therapy.
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